Mao Ouyang

855 total citations
22 papers, 681 citations indexed

About

Mao Ouyang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Mao Ouyang has authored 22 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Mao Ouyang's work include MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Mao Ouyang is often cited by papers focused on MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Mao Ouyang collaborates with scholars based in China, United States and Brazil. Mao Ouyang's co-authors include Shenming Wang, Wenjian Wang, Guangqi Chang, Jieyi Ma, Leying Zhang, Weiming Lv, Behnam Badie, Xuebo Chen, Shihua Wu and Huaqing Wang and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Mao Ouyang

21 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mao Ouyang China 12 400 298 171 95 91 22 681
Feng Hu China 14 278 0.7× 187 0.6× 249 1.5× 83 0.9× 131 1.4× 28 647
Dauren Biyashev United States 15 484 1.2× 268 0.9× 171 1.0× 177 1.9× 127 1.4× 27 855
Xuebo Chen China 12 273 0.7× 144 0.5× 207 1.2× 97 1.0× 100 1.1× 15 548
Rajshekhar A. Kore United States 13 369 0.9× 220 0.7× 91 0.5× 60 0.6× 29 0.3× 24 552
Nicolas Malaquin Canada 16 545 1.4× 112 0.4× 247 1.4× 188 2.0× 46 0.5× 20 1.0k
Yuanyuan Ling China 6 343 0.9× 71 0.2× 201 1.2× 73 0.8× 45 0.5× 10 872
Kateřina Rohlenová Czechia 9 383 1.0× 236 0.8× 78 0.5× 65 0.7× 18 0.2× 18 618
Xuelei Ruan China 23 988 2.5× 787 2.6× 76 0.4× 78 0.8× 53 0.6× 49 1.2k
Renbing Jia China 9 682 1.7× 389 1.3× 125 0.7× 154 1.6× 22 0.2× 20 938
Deguan Lv China 18 561 1.4× 265 0.9× 143 0.8× 175 1.8× 48 0.5× 25 1.1k

Countries citing papers authored by Mao Ouyang

Since Specialization
Citations

This map shows the geographic impact of Mao Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao Ouyang more than expected).

Fields of papers citing papers by Mao Ouyang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mao Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao Ouyang. The network helps show where Mao Ouyang may publish in the future.

Co-authorship network of co-authors of Mao Ouyang

This figure shows the co-authorship network connecting the top 25 collaborators of Mao Ouyang. A scholar is included among the top collaborators of Mao Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mao Ouyang. Mao Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoyu, Wenxin Li, Xintian Xu, et al.. (2025). TRAP1 inhibits KANSL3 acetylation to alleviate mitochondrial dysfunction by promoting mitophagy in cardiomyocytes under diabetic conditions. Cell Communication and Signaling. 23(1). 414–414.
2.
Xu, Xintian, Lingxiao Zhang, Xiaoyu Zhang, et al.. (2024). Thromboembolism adverse event profiles of thrombopoietin receptor agonists: a real-world, pharmacovigilance study. Expert Opinion on Drug Safety. 23(12). 1531–1543. 2 indexed citations
3.
Xu, Xintian, et al.. (2023). Protective effect of uridine on atrial fibrillation: a Mendelian randomisation study. Scientific Reports. 13(1). 19639–19639. 3 indexed citations
5.
Zhang, Yitao, et al.. (2021). The predictive value of high-sensitive troponin I for perioperative risk in patients undergoing gastrointestinal tumor surgery. EClinicalMedicine. 40. 101128–101128. 5 indexed citations
7.
Ouyang, Mao, Qin Guo, Jia Jia, et al.. (2019). Changes in the intestinal microecology induced by bacillus subtilis inhibit the occurrence of ulcerative colitis and associated cancers: a study on the mechanisms.. PubMed. 9(5). 872–886. 16 indexed citations
8.
Liu, Hongtao, et al.. (2018). Matrix Factorization Recommendation Algorithm Based on User Characteristics. 2007. 33–37. 4 indexed citations
9.
Li, Jie, Yuanhui Lai, Jieyi Ma, et al.. (2017). miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer. BMC Cancer. 17(1). 745–745. 91 indexed citations
10.
Ouyang, Mao, Hui Ren, Qin Guo, et al.. (2016). Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model. PLoS ONE. 11(2). e0148139–e0148139. 33 indexed citations
11.
Zhang, Ian, Darya Alizadeh, Junling Liang, et al.. (2016). Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages. PLoS ONE. 11(12). e0165118–e0165118. 42 indexed citations
12.
Ouyang, Mao, et al.. (2015). Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats. BMC Cardiovascular Disorders. 15(1). 42–42. 19 indexed citations
13.
Ouyang, Mao, Hua Wang, Jieyi Ma, et al.. (2015). COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer. BMC Cancer. 15(1). 132–132. 22 indexed citations
14.
Jiang, Weihong, et al.. (2015). PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.. PubMed. 8(2). 2097–107. 15 indexed citations
15.
Chen, Xuebo, Leying Zhang, Junling Liang, et al.. (2014). RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma. Cancer Research. 74(24). 7285–7297. 132 indexed citations
16.
Ouyang, Mao, Yongxin Li, Sheng Ye, et al.. (2014). MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer. PLoS ONE. 9(5). e96228–e96228. 162 indexed citations
17.
Li, Yongxin, Mao Ouyang, Zhen Shan, et al.. (2014). Involvement of MicroRNA-133a in the Development of Arteriosclerosis Obliterans of the Lower Extremities via RhoA Targeting. Journal of Atherosclerosis and Thrombosis. 22(4). 424–432. 13 indexed citations
18.
Ouyang, Mao, et al.. (2014). Olecular mechanism underlying the myeloperoxidase induced apoptosis of HUVEC-12 cells.. PubMed. 7(4). 879–85. 1 indexed citations
19.
Wang, Huaqing, Leying Zhang, Xuebo Chen, et al.. (2013). S100B Promotes Glioma Growth through Chemoattraction of Myeloid-Derived Macrophages. Clinical Cancer Research. 19(14). 3764–3775. 78 indexed citations
20.
Cao, Yu, et al.. (2010). Correlation between plasma asymmetric dimethylarginine and different types of coronary heart disease.. PubMed. 35(4). 301–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026